Monica Raymunt


EU court poised to make landmark ruling on CBD in Europe

Five judges on the European Union’s top court in Luxembourg are set to rule on the legality of France’s ban on hemp-derived CBD – and potentially upend the future of Europe’s hemp industry in the process. Thursday’s ruling from the Court of Justice of the European Union on the so-called Kanavape case is one of […]

Read More

Report: Chinese hemp company lands $75 million investment from pharma giant

China’s biotech and pharma giant Tasly Holding Group has announced a 500 million yuan ($75.6 million) investment into biotech company Puyuan Miaosheng Group’s industrial hemp subsidiary. The investment will be used to develop Yunnan Maye Biotech’s operations in hemp farming, foods and beverages, pet food, new tobacco products and vaporizers, and biopharmaceutical products in five […]

Read More

Italian economists: High-CBD hemp flower cut into illicit MJ market, hurt organized crime

The availability of hemp flower containing up to 0.6% THC in Italy led some marijuana users to abandon their illicit products, costing criminal networks tens of millions, a trio of economists has found. The researchers’ findings, published last year in the European Economic Review, suggest Italy’s criminal organizations lost tens of millions of euros after […]

Read More

2020 survival strategies: Why Elixinol cut half its workforce, halted production and refocused for future growth

Hemp-derived CBD supplement maker Elixinol shed half of its global workforce and shuttered production lines in the first half of this year in response to market decline stemming from the global COVID-19 pandemic. Now the Australian company is looking to leverage a leaner operation and focus on its core CBD brands for future success. Talking […]

Read More